26th Annual ESGO 2025 Congress
Discover it Now!
Discover the new clinical calculators for cervical cancer recurrence risk and post-recurrence survival prediction, based on a model applicable to patients with early-stage disease.
Watch the video with David Cibula and Daniela Fischerova introducing the new calculators in a simple and exciting manner.
The risk calculator model is applicable for patients with early-stage cervical cancer (T1a–T2b) after primary surgical treatment and l can be used to plan an individual surveillance strategy based on prognostic factors.
The model is based on data from 4,343 patients treated in 20 tertiary centres on 4 continents. View Article
Get started and enter the tumour characteristics to determine the annual recurrence risk and disease-free survival.
This prediction model is applicable for patients experiencing recurrence who previously underwent primary surgical treatment for early-stage disease (stage T1a–T2b).
The model is based on data from 528 patients who relapsed after primary treatment, that were obtained from SCCAN database containing 4,343 patients treated in 20 tertiary centres on 4 continents. View Article
Get started and enter the tumour characteristics at the time of primary treatment and the disease recurrence to predict the post-recurrence disease specific survival.